Active Ingredient: DROXIDOPA
Proprietary Name: DROXIDOPA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A214017
Product Number: 001
Approval Date: Feb 18, 2021
Applicant Holder Full Name: SCIEGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information